Researchers at the Icahn School of Medicine at Mount Sinai have found that patients with Parkinson's disease undergoing deep brain stimulation (DBS) show little to no Lewy pathology in the prefrontal ...
For patients with Parkinson's disease, changes in their ability to walk can be dramatic. "Parkinson's gait," as it is often called, can include changes in step length and asymmetry between legs. This ...
The limits of standard brain stimulation For decades, doctors have used deep brain stimulation (DBS) to treat neurological ...
Persons with Parkinson's disease increasingly lose their mobility over time and are eventually unable to walk. Hope for these patients rests on deep brain stimulation, also known as a brain pacemaker.
Parkinson’s disease is a debilitating neurological condition that affects movement, causing tremors, stiffness and freezing ...
An international team has succeeded in using a magnetic field to target structures deep within the brain. The researchers ...
Researchers in Switzerland have created an AI-assisted therapy to treat Parkinson's patients with walking problems. The ...
A new study led by Bucknell University Professor Karlo Malaga, biomedical engineering, has identified key insights into optimizing deep brain stimulation (DBS) for Parkinson's disease patients.
Subthalamic nucleus deep brain stimulation (STN-DBS) provides lasting benefits for patients with moderate-to-advanced Parkinson’s disease (PD), with sustained improvements in movement and quality of ...
Drawing on its leadership in advanced neurosciences, Manipal Hospital Sarjapur Road recently hosted the Manipal DBS Summit 2026, the first dedicated scientific meeting in India focused exclusively on ...
Medtronic has won FDA approval for a device that can help with therapy for those suffering from Parkinson’s Disease. The Dublin-based company’s BrainSense Adaptive deep brain stimulation (aDBS) and ...
Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...